Alex Knapp, Forbes Staff

Author's posts

What You Need To Know About Pfizer’s Covid-19 Vaccine

Developed with Pfizer’s partner BioNTech, if all goes well this vaccine would be the first of its kind to receive FDA approval.

How The Biden Presidency Plans To Combat Covid-19

Free testing, mask mandates, vaccine distribution and clear public guidance form the cornerstones of the President-elect’s pandemic response.

Meet The Married Couple Who Just Raised $10 Million To Improve Cancer Treatments For Dogs

Ben Lewis and Christina Lopes just finalized a series A for their company, One Health, which is working to improve medical treatments for dogs — in ways that could improve cancer care in humans as well.

Lilly’s Rheumatoid Arthritis Drug, Combined With Remdesivir, Benefits Covid-19 Patients Who Need Oxygen

Lilly announced additional findings indicating that its rheumatoid arthritis drug, baricitinib, may improve the health of severe Covid-19 patients when used in combination with Gilead Science’s antiviral drug remdesivir.

This Startup Has Raised Nearly $100 Million To Make Good On The Promise Of AI For Drug Discovery

Flagship Pioneering’s David Berry founded Valo Health 18 months ago with an eye to making an AI platform to develop drugs more quickly and efficiently.

Lilly’s Rheumatoid Arthritis Drug Shortens Covid-19 Hospitalization When Combined With Antiviral Med

The pharmaceutical company said its drug baricitinib, combined with remdesivir, reduces median hospital stays by one day compared to remdesivir alone, and is pursuing an emergency use authorization with the FDA.

2021 Breakthrough Prize Winners Announced: Researcher Who Developed Protein Design Technology Awarded $3 Million

David Baker, whose protein design technology is being used to develop therapies for Covid-19 and cancer, received one of several awards to scientists from the Breakthrough Prize Foundation that add up to a combined total of $21.75 million.

The Inside Story Of Biotech’s Barnum And His Covid Cures

Billionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat “the crisis of our time.”

Mammoth Biosciences Signs Exclusive Deal For Recently-Discovered Crispr Protein

Biotech company Mammoth Biosciences has signed an exclusive deal with University of California Berkeley to license a newly-discovered class of Crispr proteins.

This Startup Aims To Bring Hospital-Grade Disinfection To Hotels, Restaurants And Schools

This group of Silicon Valley veterans have joined forces with an environmental scientist to bring hospital grade UV-C disinfection to schools and to businesses like hotels and restaurants.